Summary unavailable.

Questions

Question 1

Which group of antianginal medications is specifically indicated for the acute treatment of angina pectoris attacks?

View answer and explanation
Question 2

What are the two primary mechanisms of action for nitrates in the treatment of angina?

View answer and explanation
Question 3

Which antianginal agent is specifically mentioned as working by decreasing myocardial oxygen consumption, separate from the action of beta blockers?

View answer and explanation
Question 4

According to the provided text, what is the primary mechanism by which beta blockers exert their antianginal effect?

View answer and explanation
Question 5

Which medication group is used prophylactically in the long-term management of angina but is NOT indicated for acute attacks?

View answer and explanation
Question 6

Which condition is listed as a contraindication for the use of beta blockers in a patient with angina?

View answer and explanation
Question 7

The use of beta blockers as an antianginal agent requires caution in patients with which of the following co-existing conditions?

View answer and explanation
Question 8

Concurrent use of nitrates with other antihypertensive medications may lead to what potential adverse effect?

View answer and explanation
Question 9

Combining verapamil, a calcium channel blocker, with a beta blocker can result in what specific type of interaction?

View answer and explanation
Question 10

What advice should a nurse provide to a patient taking antianginal medications to help minimize orthostatic hypotension?

View answer and explanation
Question 11

What is one of the key desired evaluation outcomes for a patient undergoing antianginal therapy?

View answer and explanation
Question 12

To prevent a hypotensive interaction, patients taking nitrates, calcium channel blockers, or beta blockers should be advised to avoid concurrent use of what substance?

View answer and explanation
Question 13

A patient taking a daily beta blocker for long-term angina management should be instructed to use which type of medication for an acute anginal attack?

View answer and explanation
Question 14

When should a patient on antianginal therapy be advised to contact a health care professional immediately regarding their chest pain?

View answer and explanation
Question 15

A patient on antianginal therapy reports the development of a severe, persistent headache. What is the most appropriate advice for the nurse to give?

View answer and explanation
Question 16

In which of the following patient populations should beta blockers be used with caution for the management of angina?

View answer and explanation
Question 17

Which of the following is NOT a primary group of medications used for the long-term prophylactic management of angina?

View answer and explanation
Question 18

How do calcium channel blockers primarily function as an antianginal agent according to the text?

View answer and explanation
Question 19

Which of the following medications is provided as an example of a nitrate used in the treatment of angina pectoris?

View answer and explanation
Question 20

Untreated heart failure is mentioned as a contraindication for the use of which two classes of antianginal drugs?

View answer and explanation
Question 21

The systemic vasodilation caused by nitrate therapy leads to a decrease in which specific hemodynamic parameter?

View answer and explanation
Question 22

Which of the following is listed as a potential nursing diagnosis for a patient receiving antianginal therapy for their condition?

View answer and explanation
Question 23

What is a key assessment parameter that a nurse should monitor periodically throughout antianginal therapy?

View answer and explanation
Question 24

What is one of the primary therapeutic goals listed under the 'Evaluation/Desired Outcomes' for a patient receiving antianginal therapy?

View answer and explanation
Question 25

What is the general action of the antianginal medication Ranolazine?

View answer and explanation
Question 26

The use of which two specific calcium channel blockers with beta blockers is noted to cause additive myocardial depressant effects?

View answer and explanation
Question 27

In addition to diabetes mellitus and hypothyroidism, in which other condition should beta blockers be used with caution?

View answer and explanation
Question 28

Which statement accurately describes the use of combination therapy for the treatment of angina pectoris?

View answer and explanation
Question 29

Which of the following dosage forms is NOT mentioned for nitrate therapy in the text?

View answer and explanation
Question 30

Which condition is listed as a contraindication for using calcium channel blockers to treat angina?

View answer and explanation
Question 31

What crucial nursing assessment related to the patient's symptoms should be performed throughout antianginal therapy?

View answer and explanation
Question 32

What specific instruction should be given to a patient about taking concurrent prophylactic antianginals and as-needed nitrate therapy?

View answer and explanation
Question 33

Which two antianginal agents are specifically highlighted as having a number of other significant drug-drug interactions beyond those common to the class?

View answer and explanation
Question 34

What additional mechanism of action is mentioned for some calcium channel blockers, besides the primary action of dilating coronary arteries?

View answer and explanation
Question 35

A patient is prescribed a beta blocker for angina. The nurse should confirm the patient does not have which contraindicated condition?

View answer and explanation
Question 36

What is the general purpose of using nitrate medications in the context of angina pectoris?

View answer and explanation
Question 37

Which of the following forms of nitrate medication is NOT suitable for the acute treatment of an angina attack?

View answer and explanation
Question 38

A patient on antianginal therapy should be advised to seek immediate medical attention if their unresolved chest pain is accompanied by which of the following symptoms?

View answer and explanation
Question 39

What is a common interaction that occurs when calcium channel blockers are taken with alcohol?

View answer and explanation
Question 40

Which antianginal drug group is explicitly identified in the text as working by decreasing myocardial oxygen consumption through a reduction in heart rate?

View answer and explanation
Question 41

What is a primary nursing diagnosis listed in the text that is related to the indication for using antianginal medications?

View answer and explanation
Question 42

Which of the following conditions is listed as a precaution for beta blocker use, rather than a contraindication?

View answer and explanation
Question 43

Besides dilating coronary arteries, what other primary mechanism of action do nitrates possess?

View answer and explanation
Question 44

A patient prescribed ranolazine should understand that its primary action is to achieve what effect?

View answer and explanation
Question 45

The 'General Action and Information' section states that several different groups of medications are used in the treatment of angina pectoris. Which of the following is NOT one of the groups mentioned?

View answer and explanation
Question 46

When teaching a patient about antianginal therapy, what is the crucial advice regarding alcohol consumption?

View answer and explanation
Question 47

What is the stated therapeutic rationale for using a combination of different antianginal agents?

View answer and explanation
Question 48

If a patient reports that their chest pain has worsened after starting antianginal therapy, what should the nurse advise them to do?

View answer and explanation
Question 49

Which group of antianginal medications achieves its effect on myocardial oxygen demand primarily by decreasing the heart rate?

View answer and explanation
Question 50

What is a key piece of patient teaching for an individual taking both a daily prophylactic antianginal and an as-needed nitrate?

View answer and explanation

Other chapters

HOW TO USE DAVIS'S DRUG GUIDE FOR NURSESEVIDENCE-BASED PRACTICE AND PHARMACOTHERAPEUTICS: Implications for NursesPHARMACOGENOMICSMEDICATION ERRORS: Improving Practices and Patient SafetyDETECTING AND MANAGING ADVERSE DRUG REACTIONSOVERVIEW OF RISK EVALUATION AND MITIGATION SYSTEMS (REMS)SPECIAL DOSING CONSIDERATIONSTHE CYTOCHROME P450 SYSTEMEDUCATING PATIENTS ABOUT SAFE MEDICATION USEAnti-Alzheimer's agentsAntianemicsAntianxiety agentsAntiarrhythmicsAntiasthmaticsAnticholinergicsAnticoagulantsAnticonvulsantsAntidepressantsAntidiabeticsAntidiarrhealsAntiemeticsAntifungalsAntihistaminesAntihypertensivesAnti-infectivesAntineoplasticsAntiparkinson agentsAntiplatelet agentsAntipsychoticsAntipyreticsAntirheumaticsAntiulcer agentsAntiviralsBeta blockersBone resorption inhibitorsBronchodilatorsCalcium channel blockersCentral nervous system stimulantsCorticosteroidsDiureticsHormonesImmunosuppressantsLaxativesLipid lowering agentsMinerals/electrolytes/pH modifiersNonopioid analgesicsNonsteroidal anti-inflammatory agentsOpioid analgesicsSedative/hypnoticsSkeletal muscle relaxantsThrombolyticsVaccines/immunizing agentsVitaminsDRUGS APPROVED IN CANADANATURAL/HERBAL PRODUCTSMEDICATION SAFETY TOOLSAppendix A. Recent Drug ApprovalsAppendix E. Administering Medications to ChildrenAppendix G. Pediatric Dosage CalculationsAppendix I. Controlled Substance SchedulesAppendix L. Insulins and Insulin TherapyAppendix M. Canadian and U.S. Pharmaceutical PracticesAppendix N. Routine Pediatric and Adult Immunizations